Skip to main
PLXS

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp's revenue from the Healthcare Life Sciences segment, which constitutes 40% of total revenues, demonstrated growth, with a year-over-year increase of 2% in FQ4, and an anticipated growth rate of high-single to low-double digits for FQ1 driven by multiple program ramps and recovering customer demand. The Aerospace and Defense segment is expected to witness sequential growth due to program ramps in commercial air and defense, aligning with the company's broader goal of 9-12% revenue growth for fiscal year 2026. Overall, the expected earnings growth rate is projected to outpace revenue growth significantly, showcasing the company's effective strategic implementation and operational leverage.

Bears say

Plexus Corp has experienced a decline in gross margins, falling to 9.9% from 10.1%, which indicates potential challenges in cost management and pricing power within its competitive landscape. Additionally, revenue from the Aerospace & Defense segment showed a significant decrease of 6% both quarter-over-quarter and year-over-year, raising concerns about demand stability in critical market areas. The outlook for Industrial revenues in the upcoming quarter also suggests a downward trend due to seasonality and moderating demand, compounded by broader economic signals indicating potential global growth slowdowns and manufacturing disruptions.

Plexus (PLXS) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 3 analysts, Plexus (PLXS) has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $160, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $160, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.